Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chuntao Quan"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionCancer-associated fibroblasts (CAFs) are a diverse group of cells that significantly impact the tumor microenvironment and therapeutic responses in breast cancer (BC). Despite their importance, the comprehensive profile of CAFs in BC rema
Externí odkaz:
https://doaj.org/article/fe9fd78e2e3945149ae9f889692c5ae3
Autor:
Chuntao Quan, Zhijie Wu, Juan Xiong, Manqing Li, Yu Fu, Jiaying Su, Yue Wang, Lvwen Ning, Deju Zhang, Ni Xie
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-21 (2023)
Abstract Background Cyclic-dependent kinase (CDK) 4/6 kinases, as the critical drivers of the cell cycle, are involved in the tumor progression of various malignancies. Pharmacologic inhibitors of CDK4/6 have shown significant clinical prospects in t
Externí odkaz:
https://doaj.org/article/a5d91d0d1ba44325850be52c41d08049
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 16, Iss , Pp 211-223 (2018)
Lung cancer is one of the most common malignancies. In spite of the progress made in past decades, further studies to improve current therapy for lung cancer are required. Dynamically controlled by methyltransferases and demethylases, methylation of
Externí odkaz:
https://doaj.org/article/bc2cda8ab0634b2d916ed43ebbc89774
Publikováno v:
International Journal of Biological Sciences. 19:1528-1542
Autor:
Lin Liu, Ping Yuan, Tengfei Ma, Mingyang Li, Peipei Xue, Chuntao Quan, Lu Zhang, Ling Zou, Zhe Wang, Hui Lu, Wei Wang, Fei Wang, Qin Tian, Juanjuan Xiao, Xiaofang Ni, Feng Zhu, Qiuhong Duan
Publikováno v:
Oncogene
Branched-chain α-keto acid dehydrogenase kinase (BCKDK), the key enzyme of branched-chain amino acids (BCAAs) metabolism, has been reported to promote colorectal cancer (CRC) tumorigenesis by upregulating the MEK-ERK signaling pathway. However, the
Autor:
Lin Liu, Yong Wang, Peipei Xue, Feng Zhu, Jianmin Zhang, Hui Lu, Xiaohui Zhang, Xuan Lin, Ping Yuan, Juanjuan Xiao, Dongsheng Guo, Soner Dogan, Chuntao Quan, Qiuhong Duan, Meng Yan, Changshu Ke, Sanpeng Xu
Publikováno v:
Oncotarget
// Chuntao Quan 1, * , Juanjuan Xiao 1, * , Qiuhong Duan 1 , Ping Yuan 1 , Peipei Xue 1 , Hui Lu 1 , Meng Yan 2 , Dongsheng Guo 3 , Sanpeng Xu 4 , Xiaohui Zhang 5 , Xuan Lin 6 , Yong Wang 7 , Soner Dogan 8 , Jianmin Zhang 1 , Feng Zhu 1 , Changshu Ke
Publikováno v:
Current pharmaceutical design. 23(29)
Over the last three decades, neoplasms have become the largest cause of human mortality due to both high tumor incidence and mortality. Chemotherapy is one of the main therapies employed to treat neoplasms. Although classical genotoxic drugs, such as